Advocacy

ACAAM represents the interests of academic addiction medicine specialists on topics important to the field by monitoring legislation and other public policy, signing onto letters, and developing organizational statements. This is typically done in partnership with other organizations, with ACAAM serving as an important voice for the field through its efforts.

Below are some of the latest sign-on letters and statements from the organization.

Statements

April 30, 2021: ACAAM Supports the Introduction of the Opioid Workforce Act of 2021 in the Senate

Sign-On Letters

September 1, 2021: ACAAM Signs Onto Letter Urging Support for GME Inclusion Into Budget Reconciliation Efforts in Congress

June 28, 2021: ACAAM Signs Onto Letter Regarding Proposed Distribution of the 1,000 New Medicare-Supported GME Slots Provided in the Consolidated Appropriations Act of 2021

May 18, 2021: ACAAM Signs Onto Letter Urging Congressional Leaders to Ensure Federal Support for Physician Training is Included in Legislative Efforts to Improve the Nation's Infrastructure

March 18, 2021: ACAAM Joins Nearly 70 Other Organizations in Supporting Senate Introduction of the Resident Physician Shortage Reduction Act (S. 834)

March 18, 2021: ACAAM Joins Nearly 70 Other Organizations in Supporting the House Introduction of the Resident Physician Shortage Reduction Act 

January 27, 2021: ACAAM Joins 85 Other Organizations Supporting the Addition of 1,000 new Medicare-supported GME positions in the Consolidated Appropriations Act, 2021

Leader Testimony/National Convenings

April 14, 2021: ACAAM Board Member, Deanna Wilson, testifies before the House Energy & Commerce Committee 

ACAAM Leads a National Convening at the White House Discussing the Importance of Addiction Medicine Fellowships 

To share thoughts on other legislation or public policy areas where ACAAM can be helpful, please contact Executive Director Bruce Hammond, [email protected]